Author: Patrick Ireland, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW, Australia. Copy edited by Gus Mitchell. February 2022
Lichen simplex is a chronic itchy skin disorder characterised by well demarcated, erythematous patches, and plaques of thickened leathery skin.
Erythema may be variable, and lesions may be solitary or multiple. Lichen simplex is also known as neurodermatitis, lichen simplex chronicus, and neurodermatitis circumscripta.
Localised lichen simplex on the lateral shin - a common area for this disorder
Lichen simplex on the ankles - accentuated skin markings, scale and pigmentation in skin of colour
The exact prevalence of lichen simplex chronicus is unknown, but it is relatively common and has a female preponderance with a ratio of 2:1. It most commonly occurs in mid-late adulthood, with the highest frequency in people aged 30–50 years.
Race does not appear to affect the prevalence of lichen simplex. Lichen simplex can occur in individuals with no general or other skin problems, but can occur in patients who have comorbid psychiatric conditions, primarypruriticdermatoses (particularly atopic eczema), and systemic diseases associated with pruritus.
What causes lichen simplex?
Lichen simplex results from a chronic ‘itch-scratch cycle’; following repetitiveexcoriation and scratching, well circumscribed thickened patches develop. The inciting stimulus for the itch can be due to a variety of reasons:
Neural-mediated stimulus that triggers itch — brachioradial pruritus, radiculopathy
Systemic disease associated with pruritus — uraemia, polycythaemia vera, malignancy
Environmental triggers — heat, sweat, chemical irritants, insect bite.
What are the clinical features of lichen simplex?
Lichen simplex chronicus consists of one or more lichenified patches or plaques on the skin. Lichenification that results from the chronic itching and scratching cycle causes an exaggeration of the normal skin marking creases giving a ‘criss-cross’ pattern. Other clinical features may include:
In order to investigate underlying conditions predisposing itch, serum TSH, free T4, EUC, LFTs, FBC, imaging, and other investigations may be undertaken.
What is the differential diagnosis for lichen simplex?
The following conditions should be excluded when evaluating patients with lichen simplex:
The treatment of lichen simplex can be summarised into a few key areas:
Breaking the itch-scratch cycle
Providing education
Behavioural changes
Pharmacotherapy
Applications and procedures.
General measures
Physical barriers and bandaging to reduce subconscious scratching.
Reduce stress, keep nails short, wear loose-fitting clothing.
Avoid and/or address triggers.
Treatment of the underlying systemic condition, dermatosis, or psychiatric disorder.
Emollients — aim for use at least twice daily; best applied after showering to retain moisture.
Specific measures
First-generation sedating antihistamines (e.g. phenhydramine or chlorpheniramine) for those with disruptive night-time pruritus.
Topical corticosteroids — superpotent topical corticosteroids 1–2x daily with either paste bandage or hydrocolloid occlusion for up to 4 weeks. Alternatively, a steroid impregnated tape may be used. Weaker steroids can be used in sensitive thin skin areas.
Systemic immunosuppressants, IL-4/IL-13 inhibitors, and JAK inhibitors are reported to be effective but seldom required.
What is the outcome for lichen simplex?
Lichen simplex is a chronic skin condition (hence lichen simplex chronicus). Whilst it can clear completely, it is often persistent and prone to recurrence. Treatment of the underlying condition predisposing to itch is essential to reduce recurrence in lichen simplex.
Often patients find no reprieve from lichen simplex without targeted pharmacotherapy (e.g. topical corticosteroids).
Charifa A, Badri T, Harris BW. Lichen Simplex Chronicus. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 11, 2021. eBook
Ju T, Vander Does A, Mohsin N, Yosipovitch G. Lichen Simplex Chronicus Itch: An Update. Acta Derm Venereol. 2022;102:adv00796. Published 2022 Oct 19. doi:10.2340/actadv.v102.4367 Journal
Juarez MC, Kwatra SG. A systematic review of evidence based treatments for lichen simplex chronicus. J Dermatolog Treat. 2021;32(7):684–92. doi:10.1080/09546634.2019.1708856. Journal
Liao YH, Lin CC, Tsai PP, Shen WC, Sung FC, Kao CH. Increased risk of lichen simplex chronicus in people with anxiety disorder: a nationwide population-based retrospective cohort study. Br J Dermatol. 2014;170(4):890–4. doi:10.1111/bjd.12811. Journal